Lataa...
USP21 regulates Hippo pathway activity by mediating MARK protein turnover
The Hippo pathway, which acts to repress the activity of YAP and TAZ trancriptional co-activators, serve as a barrier for oncogenic transformation. Unlike other oncoproteins, YAP and TAZ are rarely activated by mutations or amplified in cancer. However, elevated YAP/TAZ activity is frequently observ...
Tallennettuna:
| Julkaisussa: | Oncotarget |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5609986/ https://ncbi.nlm.nih.gov/pubmed/28969054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19322 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|